Page last updated: 2024-11-07

1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124528
SCHEMBL ID6348156
MeSH IDM0133203

Synonyms (11)

Synonym
1-bbpd
1-(4-bromobenzoyl)piperazine-2,3-dicarboxylic acid
94856-92-5
2,3-piperazinedicarboxylic acid, 1-(4-bromobenzoyl)-
pbb-pzda
SCHEMBL6348156
4-(4-bromobenzoyl)-piperazine-2,3-dicarboxylic acid
WDVICMJSSBICSA-UHFFFAOYSA-N
DTXSID00915241
1-(p-bromobenzoyl)-piperazine-2,3-dicarboxylic acid
PD075858

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Kynurenate and the piperazine derivatives blocked up to 80% of the synaptic response at doses of 1000 microM, with single-affinity dose-response curves."( Antagonism of lateral olfactory tract synaptic potentials in rat prepyriform cortex slices.
Cotman, CW; Ganong, AH; Hearn, TJ, 1986
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.31 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]